Andrzej MD - FSD Pharma Vice Lucid
| HUGEDelisted Stock | USD 0.09 0 4.56% |
Executive
Andrzej MD is Vice Lucid of FSD Pharma Class
| Phone | 416 854 8884 |
| Web | https://www.fsdpharma.com |
FSD Pharma Management Efficiency
The company has return on total asset (ROA) of (0.3374) % which means that it has lost $0.3374 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6403) %, meaning that it created substantial loss on money invested by shareholders. FSD Pharma's management efficiency ratios could be used to measure how well FSD Pharma manages its routine affairs as well as how well it operates its assets and liabilities.FSD Pharma Class currently holds 337.46 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. FSD Pharma Class has a current ratio of 3.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about FSD Pharma's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 6 records | EXECUTIVE Age | ||
| Daniel JD | Biofrontera | N/A | |
| Alycia Torres | Biofrontera | N/A | |
| Kai Beckmann | MERCK Kommanditgesellschaft auf | 58 | |
| Samantha Widdicombe | Biofrontera | N/A | |
| Jon MBA | Biofrontera | N/A | |
| Constantin Fest | MERCK Kommanditgesellschaft auf | 46 | |
Management Performance
| Return On Equity | -0.64 | |||
| Return On Asset | -0.34 |
FSD Pharma Class Leadership Team
Elected by the shareholders, the FSD Pharma's board of directors comprises two types of representatives: FSD Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of FSD. The board's role is to monitor FSD Pharma's management team and ensure that shareholders' interests are well served. FSD Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, FSD Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lakshmi Kotra, Chief Inc | ||
| Kevin Cassidy, Vice QualityLucid | ||
| Donal CPA, Chief Officer | ||
| Zeeshan Saeed, President Director | ||
| Dr BPHARM, CEO Director | ||
| Maryann Adesso, Corporate Secretary | ||
| Nathan CPA, Chief Officer | ||
| Andrzej MD, Vice Lucid | ||
| Anthony Durkacz, Co-Chairman of the Board | ||
| Randell Mack, President BioSciences |
FSD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is FSD Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.64 | |||
| Return On Asset | -0.34 | |||
| Current Valuation | 4.57 M | |||
| Shares Outstanding | 46.06 M | |||
| Shares Owned By Insiders | 9.74 % | |||
| Shares Owned By Institutions | 2.81 % | |||
| Number Of Shares Shorted | 176.97 K | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 91.86 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |